Product Information

ZORYVE 0.15% CREAM is a brand product labeled by Arcutis Biotherapeutics, Inc., priced at $15.3996 per GM under NDC 80610011560. Its NADAC has been published 84 times since Nov 20, 2024.

The High Outlier badge above means this manufacturer's average price in the roflumilast market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ZORYVE 0.15% CREAM

roflumilast
$15.3996per GM
High Outlier

Strength

1.5 mg/g

NDC

80610011560

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Last Updated

6/17/2026

Active Ingredients

ROFLUMILAST

Approval Type

New Drug (NDA)

FDA Application

NDA215985

On Market Since

7/9/2024

Pharmacological Classes

Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors

Price Statistics

The NADAC for ZORYVE 0.15% CREAM has been published 84 times since Nov 20, 2024, and over the history we have for it it has risen 9.3%. The table below summarizes its recorded NADAC range and movement.

Current price$15.3996 per GM
All-time high$15.3996 (Jun 24, 2026)
All-time low$14.0940 (Nov 20, 2024)
52-week high$15.3996
52-week low$14.7659
Median price$14.7762
Average price$14.9074
Largest weekly change+4.0% (Jan 1, 2025)
Weeks tracked84
Tracking sinceNov 20, 2024

Price History

1W

0.0%

1M

+0.1%

3M

+0.1%

6M

+4.1%

1Y

+4.3%

3Y

N/A

5Y

N/A

All

+9.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the roflumilast market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of ZORYVE 0.15% CREAM?

The current National Average Drug Acquisition Cost (NADAC) for ZORYVE 0.15% CREAM, manufactured by Arcutis Biotherapeutics, Inc., is $15.3996 per GM (NDC 80610011560), effective Jun 24, 2026.

How has the price of ZORYVE 0.15% CREAM changed over time?

Over the history we have for it, the NADAC for ZORYVE 0.15% CREAM has risen 9.3%. It has been tracked across 84 weekly CMS publications since Nov 20, 2024.

What are the highest and lowest recorded NADAC prices for ZORYVE 0.15% CREAM?

Since Nov 20, 2024, the NADAC for ZORYVE 0.15% CREAM has ranged from a low of $14.0940 (Nov 20, 2024) to a high of $15.3996 (Jun 24, 2026), with a median of $14.7762 per GM.

Are there cheaper alternatives to ZORYVE 0.15% CREAM?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZORYVE 0.15% CREAM, so no direct lower-cost alternative is listed.

Who manufactures ZORYVE 0.15% CREAM?

ZORYVE 0.15% CREAM (NDC 80610011560) is labeled by Arcutis Biotherapeutics, Inc., and CMS classifies it as a brand product.